Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02721043
Recruitment Status : Completed
First Posted : March 28, 2016
Last Update Posted : January 11, 2021
Information provided by (Responsible Party):
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 12, 2019
Actual Study Completion Date : June 8, 2020